CPE screening for hospital patients
Part of Infections clinical trials.
This trial tests a new way to screen patients for CPE bacteria when they are admitted to the hospital. The goal is to find colonized patients early and help reduce the spread of antibiotic resistance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are being admitted to the acute medical unit at the hospital.
- You will have a routine rectal swab to check for CPE bacteria.
- You test positive for CPE bacteria from that swab.
- You agree to have the rectal screening done and have no medical reason not to.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a special test (Xpert Carba-R) can find a type of drug-resistant bacteria, called CRE, in fluid from the lungs and in rectal swabs. It might help doctors treat lower respiratory tract infections more effectively.
This trial tests a new rapid test and infection prevention plan for patients who may carry carbapenem-resistant bacteria (CPE) in the hospital. It aims to see if faster detection and better infection control can reduce the spread of these hard-to-treat germs.
This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.
This trial tests a medicine called colistimethate sodium for people in the hospital with a serious infection (pneumonia or bloodstream infection) caused by a resistant bacteria called CRE. The goal is to see if this antibiotic can effectively treat the infection.
This trial tests whether daily cleansing with a special soap (chlorhexidine) combined with thoughtful use of antibiotics and stomach acid reducers can help prevent the spread of a tough germ called CPE (carbapenemase-producing Enterobacteriaceae) in the ICU. It aims to keep ICU patients safer from infection.
This trial tests whether a treatment called fecal microbiota transplantation (giving you a capsule of healthy bacteria from a donor) can help clear a hard-to-treat bacteria called CRE from your body. It may help prevent future infections and reduce the need for strong antibiotics.
Hear when a new Carbapenem-Resistant Enterobacteriaceae trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.